FundedIQ

Recently Funded Series B Biotechnology Startups

Updated Sep 2026

Funded Series B Biotechnology startups number 445 in FundedIQ, tracked with their funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Series B Biotechnology startup funding landscape, along with the 100 most recently funded Series B Biotechnology startups.

Cambridge and Boston hold the deepest concentrations of these companies. Series B Biotechnology startups closed 144 funding rounds over the last 24 months, 76 of them in the last 12 months, and raised $9.0B in disclosed capital. The median disclosed round is $50M, with the middle half of rounds falling between $23M and $92M.

Concentration in Cambridge and Boston defines this segment. While San Diego and San Francisco provide additional anchors, the geographic weight rests heavily in the Northeast. Fidelity maintains a strong presence across these sites. A strategy centered on these specific cities captures the primary density of the Biotechnology field, reducing the need for broad national coverage.

Series B Biotechnology funded startup statistics

Funded Series B Biotechnology startups
445
tracked in the database
Funding rounds, last 12 months
76
144 over 24 months
Disclosed capital raised, 24 months
$9.0B
138 of 144 rounds disclosed an amount
Median round size
$50M
middle half $23M to $92M

Most recent funding round on record: Sep 2026. Investors appearing most often across Biotechnology funding rounds: Eli Lilly, Fidelity, RA Capital Management.

100 most recently funded Series B Biotechnology startups

100 of 445

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

S
Boston, United States · Biotechnology
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Series B ·
$65M
P
Stockholm, Sweden · Biotechnology
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Series B ·
$16M
C
Tübingen, Germany · Biotechnology
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
Series B ·
$7.3M
G
Gaithersburg, United States · Biotechnology
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Series B ·
$93M
I
Seattle, United States · Biotechnology
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Series B ·
$77M
A
Laguna Hills, United States · Biotechnology
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in…
Series B ·
$100M
K
Honolulu, United States · Biotechnology
Kuehnle Agrosystems, Inc. specializes in biotech research and development of plant-based systems used for…
Series B ·
Undisclosed
T
Breda, Netherlands · Biotechnology
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Series B ·
$21M
O
Oakland, United States · Biotechnology
Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune…
Series B ·
$62M
O
San Francisco, United States · Biotechnology
Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused…
Series B ·
$190M
N
South San Francisco, United States · Biotechnology
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders. Its…
Series B ·
$74M
C
Skokie, United States · Biotechnology
Cour Pharmaceuticals Development Co Inc operates in the pharmaceutical sector. Cour Pharmaceuticals…
Series B ·
$50M
V
Geleen, The Netherlands · Biotechnology
Vertoro transforms woody and agricultural residues into a wide range of bio-based chemicals, materials, and…
Series B ·
$12M
H
München, Germany · Biotechnology
Series B ·
$50M
Z
Woburn, United States · Biotechnology
Zumutor is a biotechnology company focused on developing immuno-oncology therapies that harness the body's…
Series B ·
$7.3M
4
Bengaluru, India · Biotechnology
4baseCare offers advanced genomic solutions in precision oncology to assist individuals with cancer. The…
Series B ·
$4.0M
S
San Francisco, United States · Biotechnology
SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound. Its mission…
Series B ·
$125M
C
Cambridge, United States · Biotechnology
Founded by pioneering executives and scientists in RNAi, City Therapeutics is advancing next-generation…
Series B ·
$100M
O
Barcelona, Spain · Biotechnology
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…
Series B ·
$87M
C
Charlottesville, United States · Biotechnology
Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use…
Series B ·
$93M
P
Yoqne`am `illit, Israel · Biotechnology
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
Series B ·
$24M
C
Cambridge, United States · Biotechnology
CREATE Medicines is a clinical-stage biotechnology company focused on developing RNA-based immunotherapies…
Series B ·
$122M
N
Ulm, Germany · Biotechnology
Series B ·
$38M
W
Basel, Switzerland · Biotechnology
Windward Bio is a clinical-stage drug development company focused on improving outcomes for individuals with…
Series B ·
$165M
R
San Diego, United States · Biotechnology
Ray Therapeutics is a company that creates novel optogenetic gene therapies for patients with blinding…
Series B ·
$125M
R
Tokyo, Japan · Biotechnology
Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis…
Series B ·
$8.2M
S
San Francisco, United States · Biotechnology
A pharmaceutical business in the clinical stages, Spiral Therapeutics provides cutting-edge treatments for…
Series B ·
$27M
A
AnBogen Therapeutics
Nankang, Taiwan · Biotechnology
Anbogen is a clinical-stage biotechnology company dedicated to developing precision anti-cancer drugs that…
Series B ·
Undisclosed
N
San Diego, United States · Biotechnology
Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments.…
Series B ·
$100M
I
Durham, United States · Biotechnology
Incyclix Bio was established in 2020 in Durham, North Carolina by Patrick Roberts, Jay Strum, John Bisi, and…
Series B ·
$5.0M
S
San Diego, United States · Biotechnology
Sidewinder Therapeutics develops bispecific antibody-drug conjugates (ADCs) aimed at treating solid tumors.…
Series B ·
$137M
K
Cambridge, United States · Biotechnology
Kytopen develops a cell therapy platform that allows for the non-viral delivery of molecules into immune…
Series B ·
Undisclosed
C
Biotechnology
Crossbow Therapeutics develops immunotherapies that focus on engineering immune cells to target…
Series B ·
$77M
A
Cambridge, United States · Biotechnology
Atavistik Bio is a biotechnology company that specializes in the discovery and development of precision…
Series B ·
$40M
B
South San Francisco, United States · Biotechnology
BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery…
Series B ·
$60M
A
College Park, United States · Biotechnology
Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new…
Series B ·
$75M
P
Bengaluru, India · Biotechnology
Pandorum Technologies Pvt. Ltd. is a Bangalore based biotechnology company with focus on tissue engineering…
Series B ·
$18M
Q
Princeton, United States · Biotechnology
QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and…
Series B ·
$85M
P
San Diego, United States · Biotechnology
Primmune Therapeutics is developing small molecule, orally-administered toll-like receptor 7 (TLR7) agonists…
Series B ·
$8.6M
P
Cambridge, United States · Biotechnology
PAQ Therapeutics is a biotechnology company that is at the forefront of developing a different method to…
Series B ·
$38M
E
Heidelberg, Germany · Biotechnology
Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms…
Series B ·
$59M
J
Palo Alto, United States · Biotechnology
Juvena Therapeutics is a startup in the biopharmaceutical industry that has received funding and is…
Series B ·
$34M
P
Boston, United States · Biotechnology
Precede Biosciences is revolutionizing precision medicine by redefining the knowledge that can be extracted…
Series B ·
$64M
A
AbbeLight
Paris, France · Biotechnology
Abbelight offers innovative solutions in the field of super-resolution microscopy (nanoscopy) and membrane…
Series B ·
Undisclosed
D
Watertown, United States · Biotechnology
Diagonal Therapeutics is a biotechnology company that develops targeted therapies for cancer by integrating…
Series B ·
$125M
N
Cambridge, United States · Biotechnology
Nocion Therapeutics creates innovative pharmaceuticals designed to address conditions related to neurogenic…
Series B ·
$23M
B
Boca Raton, United States · Biotechnology
Biobeat develops a wearable device for continuous, noninvasive, accurate, medical-grade monitoring of vital…
Series B ·
$50M
V
Rochester, United States · Biotechnology
Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the treatment of…
Series B ·
$25M
A
San Francisco, United States · Biotechnology
Aeovian Pharmaceuticals, located in the San Francisco Bay Area, is a biopharmaceutical company focused on…
Series B ·
$55M
A
Cincinnati, United States · Biotechnology
Alphyn Biologics is a life science company that specializes in creating exclusive drug treatments for skin…
Series B ·
$25M
B
San Diego, United States · Biotechnology
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet…
Series B ·
$84M
S
Woburn, United States · Biotechnology
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs. Its RNAi portfolio…
Series B ·
$110M
P
New York, United States · Biotechnology
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients…
Series B ·
$78M
T
Lexington, United States · Biotechnology
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that…
Series B ·
$120M
G
Brisbane, United States · Biotechnology
Gate Bioscience is a biotech company that is developing a new type of medicine called Molecular Gates. These…
Series B ·
$65M
E
Changping, China · Biotechnology
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic…
Series B ·
$14M
L
Loos, France · Biotechnology
Today 1 women on 8 has a breast cancer, 40% of them will have a mastectomy to cure cancer and only 14% of…
Series B ·
$50M
E
Melbourne, Australia · Biotechnology
Ena Respiratory is a biotechnology company focused on revolutionizing the way respiratory infections are…
Series B ·
$22M
V
Boulder, United States · Biotechnology
VitriVax, a biotech startup based in Boulder, Colorado, specializes in creating a platform for vaccine…
Series B ·
$17M
B
Sunnyvale, United States · Biotechnology
BridGene Biosciences is a biotechnology organization utilizing front line chemoproteomic innovation to find…
Series B ·
$28M
P
Pittsburgh, United States · Biotechnology
Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics.…
Series B ·
$78M
K
Waltham, United States · Biotechnology
Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for…
Series B ·
$600M
K
South San Francisco, United States · Biotechnology
Kardigan is a heart health company that is changing the way cardiovascular medications are developed by…
Series B ·
$254M
S
Shenzhen, China · Biotechnology
Salus BioMed is an innovative biomedical company that specializes in developing genetic sequencing technology…
Series B ·
$7.0M
O
Oxford, United Kingdom · Biotechnology
At OXCCU, we are leading the way in scientific progress, shaping the future of sustainable energy, fuel…
Series B ·
$28M
A
Emeryville, United States · Biotechnology
Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35…
Series B ·
$45M
R
Wageningen, Netherlands · Biotechnology
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Series B ·
$28M
S
Portland, United States · Biotechnology
Sparrow Pharmaceuticals is a biopharmaceutical company that focuses on developing treatments for conditions…
Series B ·
$95M
A
Valencia, Spain · Biotechnology
In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…
Series B ·
$41M
C
Jersey City, United States · Biotechnology
Biopharmaceutical research and development company
Series B ·
$17M
E
Shanghai, China · Biotechnology
Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the…
Series B ·
$60M
M
Tsuruoka, Japan · Biotechnology
Metagen Therapeutics is a drug discovery and medical business company that utilizes microbiome science.
Series B ·
$16M
N
Cambridge, United Kingdom · Biotechnology
NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore…
Series B ·
$68M
S
Blue Bell, United States · Biotechnology
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics and…
Series B ·
$3.9M
E
Bengaluru, India · Biotechnology
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell…
Series B ·
$10M
S
Copenhagen, Denmark · Biotechnology
SNIPR Biome operates a discovery stage biotechnology company aiming to transform microbial disease treatment.…
Series B ·
$41M
S
Cambridge, United States · Biotechnology
Strand Therapeutics is a company that uses a biotechnology platform to develop gene therapies with the help…
Series B ·
$153M
A
Cambridge, United States · Biotechnology
ARTBIO is a company in the clinical stage of development that specializes in radiopharmaceutical…
Series B ·
$132M
B
Fishers, United States · Biotechnology
BiomEdit is a company that uses innovative technology to develop new probiotics, bioactives, and microbial…
Series B ·
$18M
R
Or Yehuda, Israel · Biotechnology
Restore Medical creates and offers a device-oriented treatment for congestive heart failure that enhances…
Series B ·
$23M
B
Saint-antoine, France · Biotechnology
BrainEver's new therapeutic approach is based on the research conducted by Alain Prochiantz and his team…
Series B ·
$39M
A
Gent, Belgium · Biotechnology
Animab is a biotech company that focuses on developing unique technology to enhance the health of livestock.…
Series B ·
$12M
A
San Diego, United States · Biotechnology
Actio Biosciences focuses on creating treatments for both rare and common diseases using genetics-oriented…
Series B ·
$66M
S
Barcelona, Spain · Biotechnology
SpliceBio develops genetic medicines through its innovative Protein Splicing platform, focusing on gene…
Series B ·
$135M
S
Eindhoven, Netherlands · Biotechnology
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
Series B ·
$60M
A
Oakdale, United States · Biotechnology
Alpheus Medical offers an innovative sonodynamic therapy platform for treating solid tumors and a…
Series B ·
$52M
N
South San Francisco, United States · Biotechnology
NewLimit is a biotechnology company dedicated to significantly increasing human healthspan. We are working on…
Series B ·
$130M
N
Singapore, Singapore · Biotechnology
Nuevocor, which has locations in both the United States and Singapore, is working on creating genetic…
Series B ·
$45M
S
Barcelona, Spain · Biotechnology
Seqera's software allows scientists to easily conduct complex data analysis on a large scale, helping to…
Series B ·
$26M
Z
Vancouver, Canada · Biotechnology
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar)…
Series B ·
$5.0M
A
Newark, United States · Biotechnology
Ace Vision Group is a company that specializes in medical devices and is working on eye laser technology and…
Series B ·
$29M
G
Basel, Switzerland · Biotechnology
Granite Bio is a biotechnology company working on creating new antibodies for the treatment of inflammatory,…
Series B ·
$70M
P
Lehi, United States · Biotechnology
PhotoPharmics is a medical device company in the clinical stage that is working on advanced treatments for…
Series B ·
$6.0M
O
Olaris
Framingham, United States · Biotechnology
Olaris is working to transform the way diseases are identified and managed. Using our CEREBRO platform, which…
Series B ·
Undisclosed
S
Lausanne, Switzerland · Biotechnology
SamanTree Medical is a pioneering medical device company from Switzerland that offers an innovative imaging…
Series B ·
$6.0M
A
Cambridge, United States · Biotechnology
AIRNA is an innovative biotech firm focused on developing RNA editing treatments to enhance the well-being of…
Series B ·
$155M
A
Boston, United States · Biotechnology
Series B ·
$65M
N
Dublin, Ireland · Biotechnology
Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are…
Series B ·
$11M
O
Lyon, France · Biotechnology
Osivax develops immunotherapy vaccines that aim to simplify the treatment of contagious illnesses. These…
Series B ·
$11M
L
San Francisco, United States · Biotechnology
Loyal is a biotechnology company dedicated to increasing the lifespan of dogs by creating medications that…
Series B ·
$22M

345 more funded startups

445 startups · 100 visible Unlock with FundedIQ

This page shows the 100 most recent rounds (back to Feb 2025). The full 445-company history for this listing opens on a FundedIQ plan.

Company
Location
Round
Amount

Unlock all 445 companies in this listing: full funding history, investors, and founders.

Start 14-day free trial →

Countries with the most funded Series B Biotechnology startups

Where funded Series B Biotechnology startups are headquartered, by the country on the company record.

Where are funded Series B Biotechnology startups located?

Where funded Series B Biotechnology startups are based, by the city on the company record.

Top investors in Series B Biotechnology startups

The investors named most often across funded Series B Biotechnology startups.

Investor
Companies backed
Eli Lilly
2
Fidelity
2
RA Capital Management
2

Counts companies in this segment that name the firm as a backer. Investor names entered the pipeline in July 2026, so they cover the companies funded since.

About the FundedIQ Series B Biotechnology startup funding data

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 445 funded Series B Biotechnology startups currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (6 of 144 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Series B Biotechnology startups is dated Sep 2026.

The table above shows the 100 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Series B Biotechnology startups are there?

FundedIQ tracks 445 funded Series B Biotechnology startups. This page lists the 100 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Series B Biotechnology startups raised?

Series B Biotechnology startups tracked by FundedIQ have raised $9.0B in disclosed capital across 144 funding rounds over the last 24 months, including 76 rounds in the last 12 months. 138 of those 144 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

Which countries have the most funded Series B Biotechnology startups?

United States leads with 301 companies, ahead of United Kingdom (30), France (18) and Germany (16).

Which cities have the most funded Series B Biotechnology startups?

Cambridge leads with 61 companies, then Boston (25), San Diego (23) and San Francisco (18).

Which investors back the most Series B Biotechnology startups?

Eli Lilly, Fidelity and RA Capital Management appear most often across funded Series B Biotechnology startups in the FundedIQ dataset. The count is the number of tracked companies naming each firm as a backer, so it reflects the companies on record rather than every deal a firm has ever done.

What is a typical funding round size for Series B Biotechnology startups?

The median disclosed round over the last 24 months is $50M, and the middle half of rounds fall between $23M and $92M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

How often is the Series B Biotechnology startup funding data updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Series B Biotechnology startups is dated Sep 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.